Multiphasic Calcium Sulfate Bone Repair Material

多相硫酸钙骨修复材料

• 批准号: 6832895
• 负责人: Harold Alexander
• 金额: $ 10万
• 依托单位: ORTHOGEN, LLC
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-09-08 至 2006-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6832895
• 关键词: biodegradable product; biomaterial development /preparation; biomaterial evaluation; biomaterial interface interaction; biotechnology; bone disorder; bone regeneration; calcium; cell growth regulation; chemical stability; histology; laboratory rabbit; lactates; morphometry; musculoskeletal disorder therapy; nonhuman therapy evaluation; osteogenesis; polymers; sulfates

DESCRIPTION (provided by applicant): This project evaluates the feasibility of a new multiphasic, composite bone repair material composed of calcium sulfate (CS) particulate, protected from rapid degradation by an absorbable polymer either coated on, or within, a CS matrix. Repair of bone defects often requires the use of permanent or resorbable biomaterials. These materials can comprise autogenous or allogeneic bone graft, a range of alloplastic (calcium phosphate materials, bioglass, calcium sulfate materials) materials and composite combinations of these materials. Calcium sulfate (CS) is a fully degradable material for repair of bone defects. It is one of the oldest and safest biomaterials in current use. Recent research has shown that it is biocompatible, completely degradable, osteoconductive, does not cause inflammation and evokes minimal foreign body response. It can be used in combination with other bone graft materials such as autograft, calcium phosphate, bioglass and allografts. It has strong hemostatic activity and it prevents the ingrowth of soft tissue in the defect area acting as a barrier material. It stimulates the growth of micro blood vessels and hence is angiogenic. It causes precipitation of calcium phosphate deposits as it undergoes dissolution. These precipitates stimulate and direct the formation of new bone. The principal concern and complaint by practitioners using CS is that it (dissolves) too rapidly and outpaces the formation of new bone in some applications. Poly (L Lactic acid), (PLLA) is another biomaterial used in many biomedical devices with an excellent safety record. It is biocompatible and biodegradable. Our previous studies have shown that a composite of calcium sulfate and PLLA undergoes much slower dissolution in simulated body fluid than pure CS. Calcium phosphate precipitate formed as this composite degraded (which would stimulate the formation of bone in vivo). Depending upon the ratio of CS:PLLA, the degradation rate of the composite can be controlled. The product described here represents a cement that can be formulated to dissolve at controlled rates that can be matched with bone repair for a specific surgical application. This composite would overcome the disadvantage of fast dissolution of calcium sulfate, but would still retain all of its unique properties for bone grafting. There is a ready market for a new material to fill extraction sites, enhance maxilla and mandibular bone to accept dental implants, and to speed up the osseointegration of dental implants.

描述（由申请人提供）：本项目评价了一种新型多相复合骨修复材料的可行性，该材料由硫酸钙（CS）颗粒组成，通过涂覆在CS基质上或CS基质内的可吸收聚合物防止快速降解。骨缺损的修复通常需要使用永久性或可吸收的生物材料。这些材料可以包括自体或同种异体骨移植物、一系列异体（磷酸钙材料、玻璃、硫酸钙材料）材料和这些材料的复合组合。硫酸钙（CS）是一种可完全降解的骨缺损修复材料。它是当前使用的最古老、最安全的生物材料之一。最近的研究表明，它具有生物相容性，完全可降解，骨传导性，不会引起炎症和引起最小的异物反应。它可以与其他骨移植材料，如自体骨、磷酸钙、玻璃和同种异体骨联合使用。它具有很强的止血活性，并作为屏障材料防止缺损区软组织向内生长。它刺激微血管的生长，因此是血管生成的。当它溶解时，会引起磷酸钙沉淀。这些沉淀物刺激和指导新骨的形成。使用CS的从业者的主要担忧和抱怨是，它（溶解）太快，在某些应用中超过了新骨的形成。聚（L-乳酸）（PLLA）是另一种用于许多生物医学器械的生物材料，具有良好的安全记录。它具有生物相容性和生物降解性。我们以前的研究表明，硫酸钙和PLLA的复合物在模拟体液中的溶解速度比纯CS慢得多。随着该复合材料降解，形成磷酸钙沉淀物（这将刺激体内骨的形成）。根据CS：PLLA的比例，可以控制复合材料的降解速率。此处描述的产品代表了一种骨水泥，其可配制为以受控速率溶解，可与特定手术应用的骨修复相匹配。这种复合材料将克服硫酸钙快速溶解的缺点，但仍保留其用于骨移植的所有独特性能。有一个现成的市场的新材料，以填补拔牙部位，加强上颌骨和下颌骨接受牙种植体，并加快骨整合的牙种植体。